CAR-T cell therapy for bladder cancer

Chimeric antigen receptor T-cell therapy · Shenzhen Geno-Immune Medical Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR-T cell therapy for bladder cancer, covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: Intervention of Bladder Cancer by CAR-T [Phase 1, Phase 2]